CBT-Intervention for panic disorder in primary care: 5 years follow-up of a cRCT during the Covid-19 pandemic.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2023
Historique:
received: 22 12 2022
accepted: 08 06 2023
medline: 3 7 2023
pubmed: 30 6 2023
entrez: 30 6 2023
Statut: epublish

Résumé

A practice team-based exercise programme with elements of cognitive behavioural therapy (CBT) and case management for patients with panic disorder with or without agoraphobia in primary care showed significant positive effects. Here, we analyse the long-term effects (>5 years) of this intervention in the stressful context of the Covid-19 pandemic. All participants of the original PARADIES cluster randomized controlled trial (cRCT; 2012-2016) were invited to participate in a follow-up during the Covid-19 pandemic. Clinical outcomes were anxiety symptoms, number and severity of panic attacks, agoraphobic avoidance behaviour, Covid-specific anxiety symptom severity, depression, and patient assessment of chronic illness care. Data were analysed cross-sectionally for group differences (intervention, control) and longitudinally (T0: baseline, T1: 6 months and TCorona: >60 months). Of the original 419 participants, 100 participated in the 60 months follow-up (October 2020-May 2021). In the cross-sectional analysis, the anxiety symptom severity in the intervention group was lower than in the control group (p = .011, Cohen's d = .517). In the longitudinal analysis, both groups showed an increase of anxiety and depression symptoms compared to pre-pandemic level. The intervention may have had a lasting impact regarding anxiety severity despite the challenging context of the Covid-19 pandemic. However, we cannot say to what extend the intervention still played a role in participants' lives; other factors may also have helped with coping. The increase of anxiety and depression symptoms in both groups over time could be attributed to external circumstances.

Identifiants

pubmed: 37390059
doi: 10.1371/journal.pone.0287718
pii: PONE-D-22-35026
pmc: PMC10313059
doi:

Types de publication

Randomized Controlled Trial Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0287718

Informations de copyright

Copyright: © 2023 Lukaschek et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Am J Manag Care. 2012 Feb 01;18(2):e55-60
pubmed: 22435885
Int Clin Psychopharmacol. 1995 Jun;10(2):73-81
pubmed: 7673659
Cogn Behav Ther. 2020 Jul;49(4):270-293
pubmed: 31303121
Health Aff (Millwood). 2001 Nov-Dec;20(6):64-78
pubmed: 11816692
Psychother Psychosom. 2019;88(4):225-235
pubmed: 31121580
J Psychiatr Res. 2011 Feb;45(2):262-8
pubmed: 20609450
Behav Res Ther. 1985;23(1):35-44
pubmed: 3985915
Psychiatr Prax. 2018 Apr;45(3):160-163
pubmed: 28499315
JAMA Psychiatry. 2020 Mar 1;77(3):265-273
pubmed: 31758858
Healthcare (Basel). 2022 Jun 30;10(7):
pubmed: 35885751
Behav Res Ther. 1993 Jan;31(1):1-8
pubmed: 8093337
J Anxiety Disord. 2021 Apr;79:102385
pubmed: 33774557
J Affect Disord. 2020 Dec 1;277:977-985
pubmed: 33065842
BMC Psychiatry. 2020 May 24;20(1):259
pubmed: 32448206
J Consult Clin Psychol. 2014 Jun;82(3):375-91
pubmed: 24447006
Int J Ment Health Addict. 2022;20(3):1537-1545
pubmed: 32226353
Cochrane Database Syst Rev. 2016 Apr 13;4:CD011004
pubmed: 27071857
JAMA. 1999 Nov 10;282(18):1737-44
pubmed: 10568646
Shoulder Elbow. 2021 Oct;13(5):544-551
pubmed: 34659489
Eur Arch Psychiatry Clin Neurosci. 2022 Jun;272(4):571-582
pubmed: 34609587
BMC Fam Pract. 2011 Jul 04;12:66
pubmed: 21726443
Behav Res Ther. 2013 Feb;51(2):82-6
pubmed: 23262115
Psychol Med. 2023 Feb;53(3):614-624
pubmed: 37132646
Nat Med. 2022 Oct;28(10):2027-2037
pubmed: 36192553
Sci Rep. 2023 Apr 26;13(1):6840
pubmed: 37100805
J Consult Clin Psychol. 2003 Aug;71(4):821-5
pubmed: 12924687
Lancet. 2021 Nov 6;398(10312):1700-1712
pubmed: 34634250
Med Care. 2005 Dec;43(12):1164-70
pubmed: 16299426
Dtsch Arztebl Int. 2019 Mar 8;116(10):159-166
pubmed: 30995952
Cognit Ther Res. 2012 Oct 1;36(5):427-440
pubmed: 23459093

Auteurs

Karoline Lukaschek (K)

Institute of General Practice and Family Medicine, University Hospital, LMU Munich, Munich, Germany.

Carolin Haas (C)

Institute of General Practice and Family Medicine, University Hospital, LMU Munich, Munich, Germany.
Graduate Program "POKAL-Predictors and Outcomes in Primary Care Depression Care" (DFG-GrK 2621), Munich, Germany.

André Wannemüller (A)

Mental Health Research and Treatment Center, Ruhr-University Bochum, Bochum, Germany.

Christian Brettschneider (C)

Department of Health Economics and Health Services Research, Hamburg Center for Health Economics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Tobias Dreischulte (T)

Institute of General Practice and Family Medicine, University Hospital, LMU Munich, Munich, Germany.

Jürgen Margraf (J)

Mental Health Research and Treatment Center, Ruhr-University Bochum, Bochum, Germany.

Jochen Gensichen (J)

Institute of General Practice and Family Medicine, University Hospital, LMU Munich, Munich, Germany.
Institute of General Practice and Family Medicine, Jena University Hospital, Jena, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH